Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com.
About Edwards Lifesciences
Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, X and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240717144899/en/
Edwards Lifesciences Corp. Aktie
Starkes Kaufinteresse bei Edwards Lifesciences Corp., mit einer großen Anzahl an Buy- und wenigen Sell-Einschätzungen.
Ein Kursziel von 83 € für Edwards Lifesciences Corp. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 57.33 € bedeuten.
